Peter E. Boyd - 14 Jun 2022 Form 4 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Role
SVP-Bus. Process & Info. Tech.
Signature
/s/ Lori J. Braender, as Attorney-in-Fact
Issuer symbol
AQST
Transactions as of
14 Jun 2022
Net transactions value
+$4,050
Form type
4
Filing time
15 Jun 2022, 10:24:07 UTC
Previous filing
10 Jun 2022
Next filing
08 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AQST Common Stock Purchase $4,050 +5,000 +9.2% $0.8100 59,532 14 Jun 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple transactions at the price of $0.81. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and price at which the transaction was effected.